EAST-ASIA PHARMACEUTICAL
60517715.653.64% ( +0.55 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: EAST-ASIA PHARMACEUTICAL(605177) the Revenue is 264.57 M (+38.58%);the EBIT is -15.03 M (-441.7%);the EPS is -0.31 (-416.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.26B38.58%
----
----
EBIT
-0.02B441.74%
----
----
EPS
-0.31416.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf